The Compounding Tortoise

The Compounding Tortoise

Home
Deep Dives
Our Portfolio
Partner Q&A
Coffee Can
Key Concepts
Webinars
Weekly Digest
Earnings Recaps
Letters to Our Partners
Archive
About

Weekly Digest

Why Position Sizing is Underrated
Plus earnings reports from serial acquirers, growing profits when invested capital declines
 • 
The Compounding Tortoise
4
Adding Slightly to Two Existing Positions
Projected returns exceed our hurdle rate
 • 
The Compounding Tortoise
2
Where to Invest in Q3 - Our Picks
Our companies delivered close to 15% year-over-year growth in NOPAT/share
 • 
The Compounding Tortoise
TSS Closes Cipal Schaubroeck Acquisition
Plus: adding to an overweight position, and discussing Harvia's product innovation and OPEX structure
 • 
The Compounding Tortoise
2
Why the ROIIC + Growth + FCF Optionality Framework is Underappreciated
Preserving compounding during the tough times: a couple of excellent and not so excellent examples
 • 
The Compounding Tortoise
Our Buy List
Here's our game plan for today - we've already added to European positions
 • 
The Compounding Tortoise
3
Each New Crisis Narrows a Quality Investor's Investable Universe
This time: tariffs, crashing consumer confidence, higher savings rate, rising core inflation
 • 
The Compounding Tortoise
5
When Selling Decisions Teach Us Valuable Lessons
Constantly striving to optimize our quality growth portfolio
 • 
The Compounding Tortoise
4
VIX Index Spiking to >25%
Why buying the dip could make a lot of sense
 • 
The Compounding Tortoise
Exor Cutting Its Ferrari Stake by Roughly 16%
Ferrari repurchased 300 million EUR at €450/share
 • 
The Compounding Tortoise
3
Adding to a Long-Time Winner
Substantial growth runway is still under-appreciated
 • 
The Compounding Tortoise
6
Is There FOMO in Quality Land?
+ Topicus with a new equity investment worth 170 million EUR
 • 
The Compounding Tortoise
© 2025 The Compounding Tortoise
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture